Stay updated with breaking news from Exact Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Hussman Strategic Advisors Inc. grew its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Free Report) by 400.0% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 31,500 shares of the medical research company’s stock after buying an additional 25,200 shares […]
Exact Sciences Co. (NASDAQ:EXAS – Get Free Report) was the target of some unusual options trading activity on Tuesday. Investors purchased 16,937 call options on the company. This is an increase of 291% compared to the average volume of 4,328 call options. Insider Activity at Exact Sciences In other Exact Sciences news, CEO Kevin T. […]
The increasing need for radioimmunoassay is mainly driven by the rising occurrence of cancer, infectious diseases, and various other health conditions, along...
The increasing need for radioimmunoassay is mainly driven by the rising occurrence of cancer, infectious diseases, and various other health conditions, along with a growing number of epidemics and pandemics and increasing health awareness. Moreover,...
Artisan Partners, an investment management company, released its “Artisan Mid Cap Fund” first quarter 2024 investor letter. A copy of the same can be downloaded here.